B4GALNT2 Antikörper
-
- Target Alle B4GALNT2 Antikörper anzeigen
- B4GALNT2 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser B4GALNT2 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Fusion protein of human B4GALNT2
- Isotyp
- IgG
- Top Product
- Discover our top product B4GALNT2 Primärantikörper
-
anti-beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) (AA 324-566) antibody
B4GALNT2 Reaktivität: Human IHC, WB, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) (AA 324-566) antibodyB4GALNT2 Reaktivität: Human IHC, WB, IP, ICC Wirt: Maus Monoclonal D5 unconjugated
anti-beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) (AA 301-566) antibodyB4GALNT2 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) (AA 126-175) antibodyB4GALNT2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) (N-Term) antibodyB4GALNT2 Reaktivität: Human, Maus ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:30-1:150, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- B4GALNT2 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2))
- Andere Bezeichnung
- B4GALNT2 (B4GALNT2 Produkte)
- Hintergrund
- B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).
- UniProt
- Q8NHY0
-
